Cover Image


View/Hide Left Panel

Smith, G.L., M.Mackett, and B.Moss. 1983. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature 302(5908):490–495.

Stevens, C.E., R.P.Beasley, J.Tsui, and W.C.Lee. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292(15):771–774.

Szmuness, W., C.E.Stevens, E.J.Harley, E.A.Zang, W.R.Oleszko, D.C. William, R.Sadovsky, J.N.Morrison, and A.Kellner. 1980. Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N. Engl. J. Med. 303:833–841.

Valenzuela, P., P.Gray, M.Quiroga, J.Zaldivar, H.M.Goodman, and W.J.Rutter. 1979. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280(5725):815–819.

Xu, Z.-Y., C.-B. Liu, D.P.Francis, R.H.Purcell, Z.L.Gun, S.C.Duan, R.J.Chen, H.S.Margolis, C.H.Huang, and J.E.Maynard. 1985. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: Preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 76:713–718.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement